Abbott Laboratories

ABT: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
d^MLOCK|@K^&LOCK|$>lXVP

Abbott Seeks To Move Further Into Medtech by Shedding Nutrition Business

Business Strategy and Outlook

Despite the disparate mix of businesses, Abbott has largely made it work. However, the firm plans to move more firmly into medtech by spinning out its nutrition business. As always, Abbott's prospects rely heavily on its ability to consistently introduce innovative products across divisions. On margins, we're pleased to see the company make steady progress over the last decade.

Sponsor Center